Arix Bioscience Plc (ARIX) Company Profile

Arix Bioscience Plc Company Snapshot

Arix Bioscience Plc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arix Bioscience Plc with three other companies in this sector in UNITED KINGDOM : Shield Therapeutics PLC (2019 sales of £719,000.00 [US$987,639.97 ] of which 100% was Feraccru), Midatech Pharma PLC (£674,000.00 [US$925,826.62 ] of which 100% was Pipeline R&D), and Physiomics PLC (£718,965.00 [US$987,591.89 ] of which 100% was Outsourced Systems and Computational Bio).

Sales Analysis.

Arix Bioscience Plc

Stock Data:

Recent Stock Performance:

Current Price (1/22/2021): 182.50p
(Figures in Pounds Sterling)

1 Week	-11.0%	13 Weeks	-14.7%

4 Weeks	69.0%	52 Weeks	90.1%

Arix Bioscience Plc Key Data:

Ticker:	ARIX	Country:	United Kingdom

Exchanges:	LON	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2019 Sales	506,000 (Year Ending Jan 2020).	Employees:	730

Currency:	Pounds Sterling	Market Cap:	247,487,617

Fiscal Yr Ends:	December	Shares Outstanding:	135,609,653

Share Type:	Ordinary	Closely Held Shares:	39,059,588

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.